GR3004330T3 - - Google Patents
Info
- Publication number
- GR3004330T3 GR3004330T3 GR920400681T GR920400681T GR3004330T3 GR 3004330 T3 GR3004330 T3 GR 3004330T3 GR 920400681 T GR920400681 T GR 920400681T GR 920400681 T GR920400681 T GR 920400681T GR 3004330 T3 GR3004330 T3 GR 3004330T3
- Authority
- GR
- Greece
- Prior art keywords
- salts
- pentopyranosyl
- naphthacene
- erythro
- anthracycline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62197032A JP2603480B2 (ja) | 1987-08-05 | 1987-08-05 | 安定化されたアンスラサイクリン系製剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3004330T3 true GR3004330T3 (el) | 1993-03-31 |
Family
ID=16367605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR920400681T GR3004330T3 (el) | 1987-08-05 | 1992-04-10 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4952566A (el) |
| EP (1) | EP0302729B1 (el) |
| JP (1) | JP2603480B2 (el) |
| KR (1) | KR970000507B1 (el) |
| AT (1) | ATE71526T1 (el) |
| AU (1) | AU609168B2 (el) |
| CA (1) | CA1324959C (el) |
| DE (1) | DE3867751D1 (el) |
| DK (1) | DK173317B1 (el) |
| ES (1) | ES2038763T3 (el) |
| FI (1) | FI91483C (el) |
| GR (1) | GR3004330T3 (el) |
| NO (1) | NO175134C (el) |
| NZ (1) | NZ225654A (el) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6300361B1 (en) | 1990-07-25 | 2001-10-09 | Novartis Ag | Stabilized pharmaceutical compositions comprising acid donors |
| HU222489B1 (hu) * | 1990-07-25 | 2003-07-28 | Novartis Ag. | Stabilizált gyógyszerkészítmények és eljárás az előállításukra |
| FR2665834B1 (fr) * | 1991-07-24 | 2001-02-23 | Sandoz Sa | Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique, et sa preparation. |
| DE19741715A1 (de) * | 1997-09-22 | 1999-03-25 | Hoechst Ag | Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung |
| ATE315571T1 (de) * | 1997-11-28 | 2006-02-15 | Dainippon Sumitomo Pharma Co | Kristallines amrubicin-hydrochlorid |
| KR100932407B1 (ko) * | 2001-10-23 | 2009-12-17 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 염산 암루비신의 안정화 |
| AU2003284478A1 (en) * | 2002-11-29 | 2004-06-23 | Sumitomo Pharmaceuticals Co., Ltd. | Freeze-dried preparation of stabilized anthracycline compound |
| CN100395255C (zh) * | 2005-02-02 | 2008-06-18 | 江苏豪森药业股份有限公司 | 马来酸氨柔比星盐及其制备方法和用途 |
| KR20070088447A (ko) * | 2005-05-11 | 2007-08-29 | 시코르, 인크. | 안정한 동결건조된 안트라사이클린 글리코시드 |
| ES2524700T3 (es) * | 2009-05-27 | 2014-12-11 | Sumitomo Dainippon Pharma Co., Ltd. | Formulación estabilizada y liofilizada de compuestos de antraciclina |
| CN104884033B (zh) * | 2012-12-19 | 2018-04-20 | 高露洁-棕榄公司 | 锌氨基酸络合物与半胱氨酸 |
| WO2016024369A1 (ja) * | 2014-08-13 | 2016-02-18 | テバ製薬株式会社 | がん治療用医薬組成物 |
| WO2019094819A2 (en) * | 2017-11-09 | 2019-05-16 | Abon Pharmaceuticals, Llc | Intravenous delivery systems for chemotherapy drugs |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2522187C2 (de) * | 1975-05-17 | 1977-10-28 | Byk Gulden Lomberg Chem Fab | Verwendung von Cystein oder dessen Säureadditionssalz und Natriumdisulfit zur Stabilisierung von injizierbaren, einen pH-Wert zwischen 7 und 9 aufweisenden, Vitamin B tief 12 und nichtsteroidal Entzündungshemmer enthaltenden Arzneimitteln |
| US4540695A (en) * | 1981-08-12 | 1985-09-10 | Sumitomo Chemical Co., Ltd. | Aminonaphthacene derivatives and their use |
| JPS5976099A (ja) * | 1982-10-22 | 1984-04-28 | Sumitomo Chem Co Ltd | アミノナフタセン誘導体とその製造方法 |
| GB8426672D0 (en) * | 1984-10-22 | 1984-11-28 | Erba Farmitalia | Pharmaceutical compositions |
-
1987
- 1987-08-05 JP JP62197032A patent/JP2603480B2/ja not_active Expired - Lifetime
-
1988
- 1988-08-01 FI FI883602A patent/FI91483C/fi not_active IP Right Cessation
- 1988-08-02 NZ NZ225654A patent/NZ225654A/en unknown
- 1988-08-02 US US07/227,135 patent/US4952566A/en not_active Expired - Lifetime
- 1988-08-03 NO NO883447A patent/NO175134C/no not_active IP Right Cessation
- 1988-08-04 AU AU20421/88A patent/AU609168B2/en not_active Expired
- 1988-08-04 DK DK198804366A patent/DK173317B1/da not_active IP Right Cessation
- 1988-08-04 EP EP88307214A patent/EP0302729B1/en not_active Expired - Lifetime
- 1988-08-04 AT AT88307214T patent/ATE71526T1/de not_active IP Right Cessation
- 1988-08-04 ES ES198888307214T patent/ES2038763T3/es not_active Expired - Lifetime
- 1988-08-04 KR KR1019880009960A patent/KR970000507B1/ko not_active IP Right Cessation
- 1988-08-04 DE DE8888307214T patent/DE3867751D1/de not_active Expired - Lifetime
- 1988-08-05 CA CA000574065A patent/CA1324959C/en not_active Expired - Lifetime
-
1992
- 1992-04-10 GR GR920400681T patent/GR3004330T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK173317B1 (da) | 2000-07-17 |
| JP2603480B2 (ja) | 1997-04-23 |
| NO175134C (no) | 1994-09-07 |
| ATE71526T1 (de) | 1992-02-15 |
| KR970000507B1 (ko) | 1997-01-13 |
| NZ225654A (en) | 1991-03-26 |
| AU609168B2 (en) | 1991-04-26 |
| DK436688D0 (da) | 1988-08-04 |
| FI91483C (fi) | 1994-07-11 |
| EP0302729B1 (en) | 1992-01-15 |
| FI883602A0 (fi) | 1988-08-01 |
| ES2038763T3 (es) | 1993-08-01 |
| FI883602A (fi) | 1989-02-06 |
| CA1324959C (en) | 1993-12-07 |
| NO883447D0 (no) | 1988-08-03 |
| KR890003791A (ko) | 1989-04-18 |
| EP0302729A1 (en) | 1989-02-08 |
| FI91483B (fi) | 1994-03-31 |
| NO175134B (no) | 1994-05-30 |
| NO883447L (no) | 1989-02-06 |
| US4952566A (en) | 1990-08-28 |
| DK436688A (da) | 1989-02-06 |
| AU2042188A (en) | 1989-02-09 |
| DE3867751D1 (de) | 1992-02-27 |
| JPS6440493A (en) | 1989-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3004330T3 (el) | ||
| IL94612A0 (en) | Preparation of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof | |
| EP0729790A3 (de) | Zentrifuge | |
| NO163574C (no) | Fremgangsmaate for fremstilling av antitumor-antibiotika (ll-e33288 kompleks) ved fermentering av micromonospora echinospora ssp. calichensis nrrl 1539 og nrrl 15975. | |
| EP0410433A3 (en) | Tylosin derivatives | |
| EP0357108A3 (en) | Platinum-(iv)-diamine complex- method for the preparation of this compound, preparation with an anti-tumour action, which contains at least one platinum compound, and shaped preparation with an anti-tumour action | |
| EP0254484A3 (en) | 6-amino anthracyclines, process for their preparation and use thereof | |
| IL87475A (en) | 4)-deshydroxyepipodo- phyllotoxin glucosides, their preparation and pharmaceutical compositions containing them | |
| DK0443471T3 (da) | 2-Deoxy-2-methylidencytidin-dihydrat, fremgangsmåder til fremstilling heraf, samt præparater | |
| FI903030A0 (fi) | Menetelmä polyprenyyliyhdistettä sisältävän farmaseuttisen koostumuksen valmistamiseksi | |
| DK0400637T3 (da) | Præparat indeholdende FR115224-substans til parenteral administration | |
| IE883358L (en) | Ethylated avermectins | |
| EP0357109A3 (en) | Platinum-(ii)-diamine complex, method for the preparation of this compound, preparation with an anti-tumour action which contains this compound and also shaped preparations with an anti-tumour action | |
| ES2036602T3 (es) | Un procedimiento de preparacion de 4'-desoxi-13(s)-dihidro-4'-yododoxorubicina. | |
| ES551678A0 (es) | Un procedimiento para la preparacion de un nuevo compuesto denominado sustancia n. 51262 por cultivo de un microorganismo del genero streptomyces | |
| ZA893917B (en) | New avermectins with a cleaved furan ring and an 8a hydroxy group | |
| ES8604087A1 (es) | Procedimiento de glicosidacion de agliconas constituidas poranalogos de la estefimicinona | |
| PT78865A (en) | 8-De:methoxy steffimycinone antibacterial and intermediates - glycosidation, e.g. with amino-sugars, of the aglycone(s) produces anthracycline antitumour agents |